Catalent Inc (NYSE:CTLT)
$ 63.48 0 (0%) Market Cap: 11.52 Bil Enterprise Value: 16.13 Bil PE Ratio: 0 PB Ratio: 3.25 GF Score: 80/100

Catalent Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 05:15PM GMT
Release Date Price: $141.03 (-0.93%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hello, everyone. Thanks for joining us on day 1 of our healthcare conference. I'm Tejas Savant, and I cover the Life Science tools and Diagnostics sector here at Morgan Stanley. I'm delighted to have Catalent join us today. And representing the company is Tom Castellano, CFO. Welcome, Tom. Before we get started, I just want to run through some important disclosures. Please see the research disclosure website for Morgan Stanley at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

With that, Tom, do you want to just go through your safe harbor quickly, and then we can begin?

Thomas P. Castellano
Catalent, Inc. - Senior VP & CFO

Yes, love to. Thanks, Tejas, for the time. Happy to be here. Looking forward to today's discussion. And just a reminder that I may make some forward-looking statements here today, and I would just draw your attention to the risk factors that were recently -- included in our recently filed 10-K that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot